Pacer Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Pacer Advisors’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,009	Closed	-$41K	–	1195
2018 Q3	$41K	Buy	+12,009	New	+$43.3K	﹤0.01%	1153
2018 Q1	–	Sell	-2,875	Closed	-$13K	–	1186
2017 Q4	$13K	Buy	+2,875	New	+$15.8K	﹤0.01%	1132

Pacer Advisors's KERX Position: Q4 2018 in Review

Pacer Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 12,009 shares — an estimated $41K sold.

Pacer Advisors first reported a position in KERX in Q4 2017 and held it in 2 quarters. The position peaked at $41K in Q3 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Pacer Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Pacer Advisors sold 12,009 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $41K.
Pacer Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q4 2017 and held it in 2 quarters.
Pacer Advisors's Keryx Biopharmaceuticals Inc position peaked at $41K in Q3 2018.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Pacer Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.